WHO issues global guideline on the use of GLP-1 medicines in treating obesity
<p>To address the growing global health challenge of obesity, which affects more than 1 billion people, the World Health Organization (WHO) has released its <a href=”https://app.magicapp.org/#/guideline/LrRxrL”>first guideline</a> on the use of Glucagon-Like Peptide-1 (GLP-1) therapies for treating obesity as a chronic, relapsing disease.</p><p>Obesity affects people in every country and was associated with 3.7 million deaths worldwide in […]
Drug Combo Tied to Lower Cancer Risk, Mortality in T2D
Dual therapy with metformin and GLP-1 RAs is associated with a lower risk for adiposity-related cancers and mortality than DPP-4 inhibitor therapy in patients with T2D. Medscape Medical News
WHO releases first guideline on the use of GLP-1 therapies for treating obesity
To address the growing global health challenge of obesity, which affects more than 1 billion people, the World Health Organization (WHO) has released its first guideline on the use of Glucagon-Like Peptide-1 (GLP-1) therapies for treating obesity as a chronic, relapsing disease.
WHO releases new guidelines around weight-loss drugs amid obesity epidemic | The World | ABC NEWS
The World Health Organisation has released guidelines recommending GLP-1-type medications as long-term treatments for obesity, issuing a global call to its member states to ensure its management is available, affordable and sustainable universally. Dr Terri-Lynne South, a dietician and chair of the RACGP Obesity Management Group, tells The World how significant this endorsement is to […]
What are GLP-1 therapies?
GLP-1 therapies are a class of medicines that help lower blood sugar, support weight loss, reduce the risk of heart and kidney complications, and can even lower the risk of early death in people with type 2 diabetes. These must be prescribed by your health care specialist and require close follow-ups. People living with obesity, […]
Danone tackles the big question for GLP-1 users: What should they eat?
Grounded in emerging research, Danone’s research and innovation team is developing nutrient-dense products tailored to every stage of the GLP-1 user journey – and meeting the needs of the broader health conscious consumer
Expanded Medicare Coverage Could Bring GLP-1s to Millions
The federal government negotiated with drug makers to bring lower prices on GLP-1 drugs to millions of Medicare patients. Medscape Medical News
FTSE 100 vs S&P 500: here’s how £10k invested at the start of the year compares
It’s been a volatile year in stock markets around the world. From tariff scares through to monetary policy shifts, investors have been left trying to dodge market corrections and carefully navigate which stocks to buy and which to avoid. But if an investor had decided to park £10k in a tracker fund of either the […]
Dr Reddy’s, Cipla, Biocon, Sun Pharma In Focus After WHO Issues Guideline On Use Of GLP-1 Drugs For Obesity
In September, the WHO added GLP-1 therapies to its Essential Medicines List for managing Type 2 diabetes in high-risk groups.
India’s GLP-1 Moment Could Reshape Sugar Market – czapp.com
India’s GLP-1 Moment Could Reshape Sugar Market czapp.com